nach oben

Erschienen in:

2014 | OriginalPaper | Buchkapitel

32. Vorgehen bei wiederholten Fehlgeburten

verfasst von : L.-M. Wallwiener, B. Toth

Erschienen in: Perikonzeptionelle Frauenheilkunde

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Das Auftreten von rezidivierenden Aborten (“recurrend spontaneous abortion”, RSA) betrifft etwa 1–3 % aller Paare im reproduktionsfähigen Alter.

Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O (2002) Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12: 63–8PubMedCrossRef

Bellver J, Meseguer M, Muriel L, Garcia-Herrero S, Barreto MA, Garda AL et al. (2010) Y chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology. Hum Reprod 25: 1713–21PubMedCrossRef

Branch W (2011) Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010. Lupus 20: 158–64PubMedCrossRef

Christiansen OB, Pedersen B, Rosgaard A, Husth M (2002) A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 17: 809–16PubMedCrossRef

Clark P, Walker ID, Langhorne P, Crichton L, Thomson A, Greaves M et al. (2010) SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 115: 4162–7PubMedCrossRef

Debbs RH, Chen J (2009) Contemporary use of cerclage in pregnancy. Clin Obstet Gynecol 52: 597–610PubMedCrossRef

Fertl KI, Bergner A, Beyer R, Klapp BF, Rauchfuss M (2009) Levels and effects of different forms of anxiety during pregnancy after a prior miscarriage. Eur J Obstet Gynecol Reprod Biol 142: 23–9PubMedCrossRef

Franssen MT, Korevaar JC, Leschot NJ, Bossuyt PM, Knegt AC, Gerssen-Schoorl KB et al. (2005) Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ 331: 137–41PubMedCrossRef

Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L (2002) Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 17: 2858–64PubMedCrossRef

Hutton B, Sharma R, Fergusson D et al. (2007) Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 114 (2): 134–142PubMedCrossRef

Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ (2009) The role of modifiable pre-pregnancy risk factors in preventing adverse fetal outcomes among women with type 1 and type 2 diabetes. Acta Obstet Gynecol Scand 88: 1153–7PubMedCrossRef

Ishikawa S, Cheung MO, Gilbert EF, Bruyere HJ Jr (1979) Acetylsalicylic acid-induced morphological changes in the ductus arteriosus of the chick embryo. Experientia 35: 92–3PubMedCrossRef

Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE (2002) Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 87: 524–9PubMedCrossRef

James AH, Brancazio LR, Price T (2008) Aspirin and reproductive outcomes. Obstet Gynecol Surv 63: 49–57PubMedCrossRef

Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamulyak K et al. (2010) Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 362: 1586–96PubMedCrossRef

Kitaya K, Yasuo T (2011) Immunohistochemistrical and clinicopathological characterization of chronic endometritis. Am J Reprod Immunol 66: 410–5PubMedCrossRef

Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD et al. (2003) Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 18: 767–73PubMedCrossRef

Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA et al. (2009) Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 36: 279–87PubMedCrossRef

Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE (2009) Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol 113: 630–5PubMed

Laurino MY, Bennett RL, Saraiya DS, Baumeister L, Doyle DL, Leppig K et al. (2005) Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors. J Genet Couns 14: 165–81PubMedCrossRef

Leong H, Stachnik J, Bonk ME, Matuszewski KA (2008) Unlabeled uses of intravenous immune globulin. Am J Health Syst Pharm 65: 1815–24PubMedCrossRef

Makrigiannakis A, Petsas G, Toth B, Relakis K, Jeschke U (2011) Recent advances in understanding immunology of reproductive failure. J Reprod Immunol 90: 96–104PubMedCrossRef

Musters AM, Repping S, Korevaar JC, Mastenbroek S, Limpens J, van der Veen F et al. (2011) Pregnancy outcome after preimplantation genetic screening or natural conception in couples with unexplained recurrent miscarriage: a systematic review of the best available evidence. Fertil Steril 95: 2153–7, 7 e1–3PubMedCrossRef

Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J (2002) Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 48: 77–86PubMedCrossRef

Nigro G, Mazzocco M, Mattia E, Di Renzo GC, Carta G, Anceschi MM (2011) Role of the infections in recurrent spontaneous abortion. J Matern Fetal Neonatal Med 24: 983–9PubMedCrossRef

Nonaka T, Takakuwa K, Ooki I, Akashi M, Yokoo T, Kikuchi A et al. (2007) Results of immunotherapy for patients with unexplained primary recurrent abortions–prospective non-randomized cohort study. Am J Reprod Immunol 58: 530–6PubMedCrossRef

Ouzounian S, Bringer-Deutsch S, Jablonski C, Theron-Gerard L, Snaifer E, Cedrin-Durnerin I et al. (2007) Hypothyroidism: from the desire for pregnancy to delivery. Gynecol Obstet Fertil 35: 240–8PubMedCrossRef

Porter TF, La Coursiere Y, Scott JR (2006) Immunotherapy for recurrent miscarriage. Cochrane Database of systematic reviews 2, Art. No.: CD000112. DOI: 10.1002/14651858.CD000112.pub2

Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368: 601–11PubMedCrossRef

Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I et al. (2008) Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 112: 320–4PubMedCrossRef

Saravelos SH, Yan J, Rehmani H, Li TC (2011) The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage. Hum Reprod 26: 3274–9PubMedCrossRef

Scarpellini F, Sbracia M (2009) Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 24: 2703–8PubMedCrossRef

Scott JR (2003) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev CD000112

Shamsi MB, Venkatesh S, Pathak D, Deka D, Dada R (2011) Sperm DNA damage & oxidative stress in recurrent spontaneous abortion (RSA). Indian J Med Res 133: 550–1PubMed

Shapiro S, Siskind V, Monson RR, Heinonen OP, Kaufman DW, Slone D (1976) Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy. Lancet 1: 1375–6PubMedCrossRef

Shokeir TA (2005) Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet 273: 50–4PubMedCrossRef

Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E et al. (2010) Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 25: 2203–9PubMedCrossRef

Stray-Pedersen B, Stray-Pedersen S (1984) Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 148: 140–6PubMedCrossRef

Takizawa T, Ikeda Y, Kawahata M, Togashi H, Yamamoto M, Arishima K et al. (1998) Increased ductal responsiveness to PGE2 after maternal treatment with aspirin and ibuprofen. J Vet Med Sci 60: 377–9PubMedCrossRef

Ticconi C, Giuliani E, Veglia M, Pietropolli A, Piccione E, Di Simone N (2011) Thyroid autoimmunity and recurrent miscarriage. Am J Reprod Immunol 66: 452–9PubMedCrossRef

Toth B, Jeschke U, Rogenhofer N, Scholz C, Wurfel W, Thaler CJ et al. (2010) Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol 85: 25–32PubMedCrossRef

Toth B, Wurfel W, Germeyer A, Hirv K, Makrigiannakis A, Strowitzki T (2011) Disorders of implantation–are there diagnostic and therapeutic options? J Reprod Immunol 90: 117–23PubMedCrossRef

Visser J, Ulander VM, Helmerhorst FM, Lampinen K, Morin-Papunen L, Bloemenkamp KW et al. (2011) Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost 105: 295–301PubMedCrossRef

Winger EE, Reed JL (2008) Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 60: 8–16PubMedCrossRef

Titel: Vorgehen bei wiederholten Fehlgeburten
verfasst von: L.-M. Wallwiener
B. Toth
Verlag: Springer Berlin Heidelberg
Buch: Perikonzeptionelle Frauenheilkunde
Print ISBN: 978-3-642-38022-8

Electronic ISBN: 978-3-642-38023-5

Copyright-Jahr: 2014
DOI: https://doi.org/10.1007/978-3-642-38023-5_32

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

32. Vorgehen bei wiederholten Fehlgeburten

Zusammenfassung

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie